Healthcare Realty Trust Incorporated (HR)
NYSE: HR · Real-Time Price · USD
18.34
+0.03 (0.16%)
At close: Sep 12, 2025, 4:00 PM EDT
18.31
-0.03 (-0.14%)
After-hours: Sep 12, 2025, 7:00 PM EDT
Healthcare Realty Trust Stock Forecast
Stock Price Forecast
The 6 analysts that cover Healthcare Realty Trust stock have a consensus rating of "Hold" and an average price target of $17.67, which forecasts a -3.65% decrease in the stock price over the next year. The lowest target is $16 and the highest is $20.
Price Target: $17.67 (-3.65%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Healthcare Realty Trust stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 1 |
| Hold | 2 | 3 | 3 | 3 | 3 | 2 |
| Sell | 3 | 2 | 2 | 2 | 2 | 2 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BTIG | BTIG | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +9.05% | Sep 10, 2025 |
| Scotiabank | Scotiabank | Hold → Buy Upgrades $18 → $20 | Hold → Buy | Upgrades | $18 → $20 | +9.05% | Sep 5, 2025 |
| Scotiabank | Scotiabank | Hold Maintains $17 → $18 | Hold | Maintains | $17 → $18 | -1.85% | Aug 28, 2025 |
| Wells Fargo | Wells Fargo | Sell Maintains $15 → $16 | Sell | Maintains | $15 → $16 | -12.76% | Aug 27, 2025 |
| JP Morgan | JP Morgan | Hold Maintains $18 → $17 | Hold | Maintains | $18 → $17 | -7.31% | Jun 26, 2025 |
Financial Forecast
Revenue This Year
1.21B
from 1.27B
Decreased by -4.35%
Revenue Next Year
1.24B
from 1.21B
Increased by 1.90%
EPS This Year
-0.32
from -1.81
EPS Next Year
-0.30
from -0.32
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 1.3B | 1.3B | ||
| Avg | 1.2B | 1.2B | ||
| Low | 1.1B | 1.1B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | -0.3% | 6.3% | ||
| Avg | -4.4% | 1.9% | ||
| Low | -11.8% | -6.8% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.09 | -0.19 | |
| Avg | -0.32 | -0.30 | |
| Low | -0.47 | -0.42 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.